{
  "id": 20999340,
  "title": "250,000 Kenyans screened for diabetes, hypertension in Boehringer programme",
  "url": "https://urgent.news/2026/11/21/250-000-kenyans-screened-for-diabetes-hypertension-in-boehringer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-21T05:10:32.000Z",
  "source": {
    "name": "Capital FM Kenya",
    "slug": "capital-fm-kenya",
    "url": "https://capitalfm.africa/250000-kenyans-screened-for-diabetes-hypertension-in-boehringer-programme/"
  },
  "original_language": "en",
  "account": "German pharmaceutical company Boehringer Ingelheim has screened over 250,000 Kenyans for diabetes and hypertension since 2022, enrolling more than 20,000 patients on treatment through its Access to Healthcare programme. The initiative, implemented in partnership with healthcare providers like Zuri Health, utilizes community outreach clinics and screening camps to reach people in underserved areas. Boehringer Ingelheim's Sustainable Development for Generations and Access to Health Manager for Sub-Saharan Africa, George Kuria, highlighted that many Kenyans only seek medical attention when symptoms arise, rather than undergoing routine health checks. This reactive approach to healthcare increases the risk of complications requiring more expensive and specialized treatments. The programme addresses disparities in healthcare access between urban and rural communities, where remote areas often lack adequate facilities and resources. Late detection of chronic illnesses not only increases healthcare costs but can also impact patients' livelihoods, particularly when complications make them unable to work. The Access to Healthcare programme includes nurse-led health coaching to help patients adhere to treatment and maintain regular medical reviews. Alongside the initiative, the World Health Organisation estimates that non-communicable diseases, such as diabetes and hypertension, resulted in approximately 18 million deaths before the age of 70 in 2021, with a significant proportion occurring in low- and middle-income countries.",
  "summary": "Boehringer Ingelheim says it has screened more than 250,000 Kenyans and placed over 20,000 on treatment for diabetes and hypertension since 2022 through its Access to Healthcare programme targeting underserved communities.",
  "key_points": [
    "Boehringer Ingelheim screened 250,000 Kenyans for diabetes and hypertension since 2022.",
    "Initiative enrolls over 20,000 patients on treatment through Access to Healthcare programme.",
    "Programme addresses healthcare access disparities between urban and rural Kenyan communities."
  ],
  "editors_take": "Scaling community-based screening and nurse-led coaching shifts the healthcare model from reactive symptom management to proactive prevention, reducing the long-term economic and physical burdens of chronic disease in underserved regions.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}